1. 167 B-cell-based vaccination elicit potent immunity against glioblastoma. (10th December 2020) Authors: Lee-Chang, Catalina; Miska, Jason; Hou, David; Rashidi, Aida; Zhang, Peng; Burga, Rachel; Horbinski, Crag; Stupp, Roger; Lesniak, Maciej Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 167 B-cell-based vaccination elicit potent immunity against glioblastoma. (9th November 2020) Authors: Lee-Chang, Catalina; Miska, Jason; Hou, David; Rashidi, Aida; Zhang, Peng; Burga, Rachel; Horbinski, Crag; Stupp, Roger; Lesniak, Maciej Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 381 Repeated Opening of the Blood-Brain Barrier With the Skull-implantable SonoCloud-9 (SC9) Device: Phase 1 Trial of Nab-Paclitaxel and SC9 in Recurrent Glioblastoma. (April 2023) Authors: Sonabend, Adam M.; Gould, Andrew; Luan, Yu; Hou, Ye; Chen, Le; Kobayashi, Mikoto; Castro, Brandyn; Zhang, Daniel; Korobova, Farida; Amidei, Christina; Youngblood, Mark William; Bebawy, John Patrick; Liu, Benjamin P.; Horbinski, Craig; Desseaux, Carole; Helenowski, Irene; Zhang, Hui; Muzzio, Migue... Journal: Neurosurgery Issue: Volume 69(2023)Supplement 1 Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-57. A PHASE 1/2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF BLOOD-BRAIN BARRIER (BBB) OPENING WITH A NINE-EMITTER IMPLANTABLE ULTRASOUND DEVICE IN RECURRENT GLIOBLASTOMA PATIENTS PRIOR TO CARBOPLATIN. (11th November 2019) Authors: Idbaih, Ahmed; Ducray, François; DeGroot, John; Stupp, Roger; Guyotat, Jacques; Lesniak, Maciej S; Sonabend, Adam; Weinberg, Jeffrey; Desseaux, Carole; Canney, Michael; Schmitt, Charlotte; Carpentier, Alexandre Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. (October 2014) Authors: Tonder, Michaela; Eisele, Günter; Weiss, Tobias; Hofer, Silvia; Seystahl, Katharina; Valavanis, Antonios; Stupp, Roger; Weller, Michael; Roth, Patrick Journal: Acta oncologica Issue: Volume 53:Number 10(2014) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of antidepressant drug use with outcome of patients with glioblastoma. Issue 7 (17th November 2022) Authors: Seliger, Corinna; Oppong, Felix Boakye; Lefranc, Florence; Chinot, Olivier; Stupp, Roger; Nabors, Burt; Gorlia, Thierry; Weller, Michael Journal: International journal of cancer Issue: Volume 152:Issue 7(2023) Page Start: 1348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Associations of anticoagulant use with outcome in newly diagnosed glioblastoma. (September 2018) Authors: Le Rhun, Emilie; Genbrugge, Els; Stupp, Roger; Chinot, Olivier L.; Nabors, L. Burt; Cloughesy, Timothy; Reardon, David A.; Wick, Wolfgang; Gorlia, Thierry; Weller, Michael Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma. Issue 1 (7th July 2022) Authors: Seystahl, Katharina; Oppong, Felix Boakye; Le Rhun, Emilie; Hertler, Caroline; Stupp, Roger; Nabors, Burt; Chinot, Olivier; Preusser, Matthias; Gorlia, Thierry; Weller, Michael Journal: Neuro-oncology advances Issue: Volume 4:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BIOM-31. ERK1/2 PHOSPHORYLATION PREDICTS SURVIVAL FOLLOWING ANTI-PD-1 IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA. (12th November 2021) Authors: Arrieta, Víctor; Chen, Andrew X; Kane, J Robert; Kang, Seong Jae; Kassab, Cynthia; Dmello, Crismita; Zhao, Junfei; Burdett, Kirsten; Upadhyayula, Pavan; Chang, Catalina; Shilati, Joseph; Jaishankar, Dinesh; Chen, Li; Gould, Andrew; Zhang, Daniel; Yuan, Jinzhou; Zhao, Wenting; Ling, Xiaoyang; Burk... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. BIOM-32. ENDOPLASMIC RETICULUM PROTEIN SSR3 DETERMINES AND PREDICTS RESPONSE TO PACLITAXEL IN BREAST CANCER AND GLIOBLASTOMA. (12th November 2021) Authors: Dmello, Crismita; Sonabend, Aarón; Arrieta, Víctor; Zhang, Daniel; Kanojia, Deepak; Chen, Li; Gould, Andrew; Kane, J Robert; Zhang, Jiangshan; Kang, Seong; Winter, Jan; Horbinski, Craig; Győrffy, Balázs; Cordero, Alex; Chang, Catalina; Castro, Brandyn; Hsu, Patrick; Ahmed, Atique; Lesniak, Maciej... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗